A multimodal cancer rehabilitation programme for women treated for female reproductive cancers: a pilot study

Not Applicable

Completed

• Conditions: Women treated for female reproductive cancers (breast, uterine, ovarian or cervical cancers); Cancer; Malignant neoplasm of breast, Malignant neoplasm of uterus, part unspecified, Malignant neoplasm of ovary, Malignant neoplasm of cervix uteri

• Registration Number: ISRCTN73177277
• Lead Sponsor: Chinese University of Hong Kong

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38977654/ (added 09/07/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-20
• Study Completion: 2022-05-31
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 35

Inclusion Criteria

1. Women with a primary diagnosis of female reproductive cancers (breast, uterine, ovarian or cervical cancers)
2. Within 3 months of completion of intensive cancer treatments (e.g. surgery, radiotherapy, and/or chemotherapy) but can be on maintenance therapies such as tamoxifen, trastuzumab and bisphosphonates
3. Over 18 years old
4. Able to understand spoken Cantonese and to read Chinese
5. Have internet-connected computing devices or smartphones

Exclusion Criteria

Those with unsuitable physical or mental health conditions, including visual impairment or pre-existing psychosis, will be excluded as their ability to comprehend information and answer questionnaires would be affected

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sense of coherence measured using the Chinese version of the Sense of Coherence 13-item Scale (CSOC-13) at baseline, completion of the intervention, and 12 weeks after completion

Secondary Outcome Measures

Name	Time	Method
1. Cancer-specific distress measured using the Chinese version of Impact of Events-Revised scale (CIES-R) ) at baseline, completion of the intervention, and 12 weeks after completion<br>2. Health-related quality of life measured using the Chinese version of the MOS 36-item Short Form (SF-36) Health Survey at baseline, completion of the intervention, and 12 weeks after completion<br>3. Participants' experiences, perceptions and opinions explored by semi-structured interviews upon completion of the intervention